Case presentation
A 58-year-old hypercholesterolemic male presented to the emergency room (ER) with palpitations, fatigue and shortness of breath. He was afebrile with an irregular heart rate (80-90 bpm), BP of 92/70 mmHg, respirations of 20/min, and an otherwise unremarkable physical examination. ECG showed atrial fibrillation (Afib) with mean heart rate of 80-90 bpm, left ventricular hypertrophy (LVH) and non-ischemic appearing ST elevation diffusely ( Figure 1A) , and he was admitted to the intensive care unit (ICU). Supplemental oxygen and intravenous fluids were given with excellent response. There were no signs or symptoms of infection. Troponin-I was 1,491.30 pg/mL. Transthoracic echo (TTE) showed mild LVH with normal left ventricular (LV) ejection fraction (EF) and segmental left anterior descending (LAD) territory hypokinesis with a normal pericardium. The working diagnosis was recent onset Afib with unstable angina. As an intermediate risk symptomatic patient, he underwent coronary computed tomography angiography (CCTA) (1) . Despite controlled Afib, a 64-MDCT scan was diagnostic, and a coronary calcium score was 76 [62nd percentile, i.e., low probability of obstructive coronary artery disease (CAD)]. CCTA showed a partially calcified mild proximal LAD stenosis (CAD-RADS 2) (2) and a non-calcified moderate mid-LAD stenosis (CAD-RADS 3) ( Figure 1B) (2) . A resting mid-inferoseptal segment perfusion defect was seen, corresponding to the mid-LAD lesion ( Figure 1C,D) . Per guidelines (3), the patient underwent invasive conventional angiography (ICA) confirming the CCTA findings, and mid-LAD stenting was performed ( Figure 1E-G) . A septal perforator and a diagonal branch were occluded during stenting, causing hemodynamically instability and heart failure requiring pharmacological support. C-reactive protein (CRP) and troponin-I peaked at 20.8 mg/dL and 5,064 pg/mL, respectively. The magnitude of the troponin level seemed out of proportion to the CAD findings and he underwent cardiac MR (CMR) to exclude myocarditis. CMR demonstrated mild LV dysfunction (LVEF 49%) with mid-LAD territory hypokinesis and normal RV function with an LV stroke volume of 87 mL. Imaging at the mid ventricular inferoseptal segment suggested a small ventricular septal defect (VSD) (Figure 2 , Figure 3 and Figure 4A -F), a CMR-calculated Qp:Qs of 1.2, mild mitral regurgitation, and a small pericardial and pleural effusion. Tissue characterization sequences suggested myocardial edema in the mid inferoseptal segment, with several late gadolinium enhancement (LGE) patterns: an ischemic area corresponding to a mid-LAD subendocardial infarction; an area of non-ischemic origin suggestive of myopericarditis; and a third region matching the VSD area described in the cine images ( Figures 4G-I) . Two days post-CMR, CRP decreased to 16.8 mg/dL, but his heart failure increased with a brain natriuretic peptide (BNP) of 829 pg/mL. Based on the CMR and laboratory results and his hemodynamic state, the patient was treated for viral myopericarditis in the setting of ischemic heart disease and acute subendocardial myocardial infarction (MI). No precordial murmur was detected. His
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Discussion
Post-MI VSD is a rare complication of acute MI. In the pre-thrombolytic era, its incidence was 1-2% (6), and has become less frequent, (0.17% to 0.31%) (7-9), due to improvements in acute reperfusion strategies (8) ; resulting in increased TIMI 3 flow, improved salvage index, and less haemorrhagic transformation of the infarcted myocardium (10) . This case is interesting since despite significant improvements in mortality for peri-infarction D © Cardiovascular Diagnosis and Therapy. All rights reserved.
Cardiovasc Diagn Ther 2017;7(2):230-234 cdt.amegroups.com management, the outcome of VSD post-MI remains poor reaching 41-80% mortality (7) (8) (9) (10) . Clinical presentations are variable depending on the size of the defect and associated factors such as RV infarction, ischemia or stunning, varying from hemodynamic stability to complete circulatory collapse (10) or death; our case had initial hemodynamic instability that resolved with pharmacological and ventilatory support.
Reports of long-term survival are rare (10), however, our patient is in NYHA class I 1 year following the event. Two recognized time periods exist for these events: an early phase that occurs in the first 24 h (as in our case) and is related to a dissection of an intramural hematoma or hemorrhage into ischemic myocardium (10); and a second phase at 3 to 5 days. The former is the mechanism in our patient as well depicted by CCTA. The vascular territory corresponding to the mid-LAD lesion showed a resting transmural perfusion defect, a well-documented capability of CT (11) . This was also well depicted by CMR (but not by echo), and showed a serpiginous defect within the mid-ventricular inferoseptal myocardium that matched the CCTA-demonstrated ischemic myocardium. The acute left to right shunt caused transient hemodynamic compromise, but was below threshold for detection by conventional echo. LGE by CMR demonstrated a small subendocardial LAD territory infarction, which was not large enough to compromise regional wall motion of that vascular territory, and therefore not detected by conventional echo; but which was confirmed by troponin-I and myoglobin. This case provides important learning points: (I) that myocarditis can coexist with ischemic heart disease (12, 13) , serving as an important inflammatory substrate complicating a typically low-risk percutaneous coronary intervention (PCI); (II) that in cases of myocarditis, CMR differentiates LGE patterns involving other pathophysiological mechanisms that elucidates the clinical diagnosis and offers better treatment options and outcomes to patients; (III) that CCTA should be considered as it demonstrates not only the presence and significance of CAD, but also associated resting perfusion defects; and (IV) that multimodality imaging is often complementary, more accurately depicts the clinical scenario and diagnosis, and results in clear patient benefit.
The co-existence of these pathological entities is possible, yet extremely rare, and increases patient risk. Clinicians should consider this clinical scenario when facing a complex myocarditis requiring vasoactive pharmacological and ventilatory support. The use of CCTA and CMR is strongly recommended to better define the pathological substrate, which can avoid unnecessary invasive procedures that place the life of the patient at risk and delay treatment, such as an endomyocardial biopsy (12, 13) . LGE of the anteroseptal and inferoseptal segments (arrow), and hyperenhancement of the pericardium.
